Christopher Boerner is Board Chair and Chief Executive Officer of Bristol Myers Squibb Co (BMY). The company reported total compensation of $21,879,919 for fiscal year 2025.
| Salary | $1,586,346 |
|---|---|
| Bonus | $0 |
| Stock awards | $16,061,399 |
| Option awards | $0 |
| Non-equity incentive plan | $3,754,684 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $477,490 |
| Total | $21,879,919 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Bristol Myers Squibb Co filed March 25, 2026, accession 0000014272-26-000006.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Board Chair and Chief Executive Officer | $1,586,346 | $0 | $16,061,399 | $0 | $3,754,684 | $0 | $477,490 | $21,879,919 |
| FY2024 | Board Chair and Chief Executive Officer | $1,536,538 | $0 | $13,643,063 | $0 | $3,235,581 | $0 | $372,436 | $18,787,618 |
| FY2023 | Board Chair and Chief Executive Officer | $1,256,921 | $0 | $5,326,178 | $0 | $1,567,098 | $0 | $311,636 | $8,461,833 |
| FY2022 | Board Chair and Chief Executive Officer | $1,064,049 | $0 | $4,256,197 | $0 | $1,274,626 | $0 | $285,348 | $6,880,220 |
| FY2021 | Chief Executive Officer | $1,020,118 | $0 | $4,095,864 | $0 | $1,313,855 | $0 | $273,192 | $6,703,029 |
| FY2020 | Executive Vice President, Chief Commercialization Officer | $952,603 | $0 | $3,210,894 | — | $1,581,713 | $0 | $247,023 | $5,992,233 |
Totals as disclosed in each year's own compensation disclosure for Bristol Myers Squibb Co.
| Peer-group chief executive median | $28,011,250 |
|---|---|
| Difference from that median | $-6,131,330 |
| Percentile within the disclosed peer group | 25th |
| Peers with a disclosed figure | 8 |
Medians and percentiles are computed across the peer group Bristol Myers Squibb Co discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Christopher Boerner this page | Board Chair and Chief Executive Officer | $21,879,919 |
| Samit Hirawat | Former EVP, Chief Medical Officer, Head of Development | $10,334,233 |
| Cristian Massacesi | EVP, Chief Medical Officer, Head of Development | $10,072,950 |
| Adam Lenkowsky | EVP, Chief Commercialization Officer | $9,340,352 |
| David Elkins | EVP and Chief Financial Officer | $9,177,590 |
| Greg Meyers | EVP and Chief Digital & Technology Officer | $7,181,173 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Bristol Myers Squibb Co compensation brief.
Christopher Boerner's compensation sits inside Bristol Myers Squibb Co's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.